West Health



Older Adults Sacrificing Basic Needs Due to Healthcare Costs

By Nicole Willcoxon, Ph.D June 15, 2022 WASHINGTON, D.C. — The health problems Americans start facing when they reach 50 years of age are compounded when the high cost of healthcare prevents them from seeking treatment, taking their prescriptions or leading an otherwise healthy lifestyle. A survey of U.S. adults conducted by West Health and… Read more »

It’s time for Medicare for All

By Sen. Bernie Sanders May 12, 2022 The United States has the most dysfunctional, inefficient, bureaucratic and expensive health care system in the world.  That’s not just what I believe.  That’s what the American people know to be true. According to a March 2022 survey by Gallup and West Health, an estimated 93 percent of American adults feel… Read more »

Brewing Alzheimer’s Drug Plan Fights Rest in Patients’ Hands

Medicare also has precedent on its side regarding coverage of other medical products developed for Alzheimer’s patients. Aduhelm isn’t the first medical product associated with Alzheimer’s disease that has been subject to a CED, said Sean Dickson, director of health policy at the West Health Policy Center.

112 million Americans struggle to pay for health care

Around 112 million Americans have trouble paying for health care, while more than 90 percent of the country believes it is not worth the cost. The data was collected by Gallup and West Health through the Healthcare Affordability Index and Healthcare Value Index

Aduhelm Pay-Formula Change Overshadowed By Other Developments

Aduhelm’s price drop in December was a windfall for providers in the first quarter of this year because Medicare was still reimbursing them the previous price plus the add-on payment, according to Sean Dickson, director of health policy for West Health.

Civica aims to launch low-cost insulin in U.S. by 2024

Non-profit drugmaker Civica said on Thursday it expects to launch lower-cost versions of insulin in the United States by 2024, to help diabetic patients struggling with high prices for the life-sustaining medicine.